Surgical Site Infection (SSI) Market Poised for Steady Growth till 2023

With every passing day, the number of surgical procedures being performed across the world is increasing, due to the rise in the prevalence of various diseases and disorders. As per the World Bank, in the U.S., the surgery rate in 2012 was 30,537 per 100,000 people. Australia recorded 28,907 surgeries per 100,000 individuals, in 2015. Surgeries are sensitive procedures, as they involve the piercing of human skin to expose internal organs, which carries a risk of infection. Even after taking all precautions, severe surgical site infections (SSI) are common, which is why the need to cure these as soon as possible is growing.

The global surgical site infection market valued $4.0 billion in 2017, and it is predicted to progress at a 6.4% CAGR during 2018–2023, to ultimately reach $5.9 billion in 2023. Apart from the increasing volume of surgeries, the prevalence of SSIs is also surging, in high- as well as low- and middle-income countries (LMIC). The European Centre for Disease Prevention and Control (ECDC) reported 18,364 SSI cases for a total of 967,191 surgeries in 2013–2014. Further, as per the National Health Surveillance Agency (ANVISA), SSIs account for almost 16% of all hospital-acquired infections in Brazil.

To Learn More About this Report@ http://bit.ly/2woqEd8

Currently, North America is the largest user of anti-SSI products, due to its huge healthcare sector, high surgery volume, presence of leading SSI product manufacturers, well-developed healthcare industry, and growing awareness on the topic. Within the region, the SSI market growth in the U.S. would be faster, as the federal government spends a considerable portion of its gross domestic product (GDP) on healthcare. The National Health Expenditure Accounts (NHEA) reported an increase of 4.3% in the nation’s healthcare spending during 2015–2016.

During the forecast period, the demand for such products would see the sharpest rise in the Asia-Pacific and Rest of the World regions, which are home to a large number of LMICs. As per the World Health Organization (WHO), one in every 10 people undergoing surgeries in LMICs get SSIs. Therefore, the WHO has a set of guidelines, known as Patient Safety Solutions, which recommend doctors to keep their hands sanitized, in order to prevent SSIs.

Therefore, as people become more aware about SSIs, the demand for preventive and therapeutic products would grow further.

Read More

Surgical Site Infection Market Will Led to Huge Growth and Share in Near Future

The surgical site infection market is growing on account of a rise in the volume of surgeries and resulting infections, growing geriatric population, and advancements in technology. The domain size, which was $4.0 billion in 2017, is expected to grow to $5.9 billion by 2023 at a CAGR of 6.4% during 2018–2023 (forecast period). By definition, the market includes all the equipment and procedures used to prevent or treat surgical infections. On the basis of phase, the market can be divided into preoperative, intraoperative, and postoperative.

Across the globe, the domain is advancing due to the growing volume of surgeries and rising incidents of SSIs. According to the World Bank, 30,537 surgeries were done per 100,000 people in the U.S. in 2012, while the number for Australia stood at 28,907 per 100,000 people. Now, a lot of surgeries, even though all preventive measures are taken, result in infections. As per the European Centre for Disease Prevention and Control, between 2013 and 2014, of the 967,191 surgeries performed in Europe, 18,364 resulted in infections. Thus, with the growing number of surgeries in the future, the incidents of infection will also increase, taking the SSI market forward.

To Learn more about this report: http://bit.ly/2o3oONH

Now, one of the primary reasons the volume of surgeries is growing is the increase in geriatric population. As the elderly are more prone to diseases requiring surgical intervention, a rise in their population will automatically propel the number of surgeries performed. Further, aged people are also more susceptible to infections on account of their low immunity, which is why such people would be another primary growth driver of the surgical site infection market during the forecast period.

Globally, North America contributed the highest revenue share (38.4%) to the domain in 2017, owing to a growing awareness about SSIs, presence of a large number of SSI product manufacturers, and developed healthcare infrastructure. While the continent will still lead the SSI market during the forecast period, Asia-Pacific will witness the fastest growth, at a 7.7% CAGR. This can be attributed to the increase in geriatric population, improvements in healthcare infrastructure, rising incidents of such infections, and penetration of advanced products for SSI prevention and management.

Therefore, it is clear that the growth in geriatric population will result in an increase in the number of surgeries, which will further the market for SSI across the world.

Read More